AI assistant
Sending…
Bone Biologics Corp — Director's Dealing 2023
Sep 14, 2023
35440_dirs_2023-09-14_3de7ec9c-e5c4-44c6-9df9-39c858533765.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2023-09-13
Reporting Person: Walsh Deina H (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | Common Stock | P | 8000 | $0.64 | Acquired | 15000 | Direct |
More from Bone Biologics Corp
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Mar 2
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 21
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Nov 7
Capital/Financing Update
2025
Sep 26
Regulatory Filings
2025
Sep 4
Regulatory Filings
2025
Aug 29